4ATH image
Deposition Date 2012-05-08
Release Date 2012-12-12
Last Version Date 2024-10-16
Entry Detail
PDB ID:
4ATH
Title:
MITF apo structure
Biological Source:
Source Organism:
MUS MUSCULUS (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.95 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR
Gene (Uniprot):Mitf
Chain IDs:A, B
Chain Length:83
Number of Molecules:2
Biological Source:MUS MUSCULUS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET SELENOMETHIONINE
Ligand Molecules
Primary Citation
Restricted Leucine Zipper Dimerization and Specificity of DNA Recognition of the Melanocyte Master Regulator Mitf
Genes Dev. 26 2647 ? (2012)
PMID: 23207919 DOI: 10.1101/GAD.198192.112

Abstact

Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte development and an important oncogene in melanoma. MITF heterodimeric assembly with related basic helix-loop-helix leucine zipper transcription factors is highly restricted, and its binding profile to cognate DNA sequences is distinct. Here, we determined the crystal structure of MITF in its apo conformation and in the presence of two related DNA response elements, the E-box and M-box. In addition, we investigated mouse and human Mitf mutations to dissect the functional significance of structural features. Owing to an unusual three-residue shift in the leucine zipper register, the MITF homodimer shows a marked kink in one of the two zipper helices to allow an out-of-register assembly. Removal of this insertion relieves restricted heterodimerization by MITF and permits assembly with the transcription factor MAX. Binding of MITF to the M-box motif is mediated by an unusual nonpolar interaction by Ile212, a residue that is mutated in mice and humans with Waardenburg syndrome. As several related transcription factors have low affinity for the M-box sequence, our analysis unravels how these proteins discriminate between similar target sequences. Our data provide a rational basis for targeting MITF in the treatment of important hereditary diseases and cancer.

Legend

Protein

Chemical

Disease

Primary Citation of related structures